Visitors Now:
Total Visits:
Total Stories:
Profile image
Story Views

Now:
Last Hour:
Last 24 Hours:
Total:

National Academy of Sciences Issues Landmark Statement on Medical Cannabis

Thursday, January 12, 2017 14:59
% of readers think this story is Fact. Add your two cents.

(Before It's News)

Alex Pietrowski, Staff Writer
Waking Times

In 2016, the Drug Enforcement Administration of the United States issued a long-awaited decision on the medical benefits of cannabis, and instead of validating what millions of people already know to be true about this healing plant, the DEA chose to keep intact the 1970 designation of cannabis as a schedule I substance, a drug which has, as they claim, no medical benefit.

Furthermore, in an even more egregious affront to justice and common sense, in December of 2016, the DEA made an overnight decision to create a new classification of schedule I drugs for cannabis extracts in order to stop the sale and consumption of CBD oil, a non-psychoactive derivative of cannabis which is known to have many health benefits.

These decisions contradict hundreds of studies, an abundance of medically verified success stories, and countless pieces of anecdotal evidence that cannabis in fact has wide-ranging medical value.


Seen as preposterous to those who support legalization, these rulings appear to be rooted in the status quo tyranny of the drug war and prison industrial complex, two monolithic cash cows which bring immense profit to those who persecute others for recreational and medical use of a plant. Now, however, this DEA’s attitude towards cannabis should come under even more scrutiny and criticism, as the National Academy of Sciences (NAS) has just released a press release which supports the claims that cannabis has therapeutic benefits.

“… the lack of any aggregated knowledge of cannabis-related health effects has led to uncertainty about what, if any, are the harms or benefits from its use.  We conducted an in-depth and broad review of the most recent research to establish firmly what the science says and to highlight areas that still need further examination.  As laws and policies continue to change, research must also.”

In the groundbreaking report released this week entitled The Health Effects of Cannabis and Cannabinoids:
The Current State of Evidence and Recommendations for Research
(2017)
, the NAS issued a comprehensive, researched-backed statement on the validity of medical marijuana, including pros and cons, outlining its clinical effectiveness.

“The report states that there is conclusive evidence that marijuana can be used as a medicine. The report did not find clinical evidence for all conditions marijuana treatment is often associated with, but it recognizes its efficacy for treating many medical conditions such as “chronic pain in adults…chemotherapy-induced nausea and vomiting and multiple sclerosis spasticity symptoms.”” [Source]

Speaking on the significance of a statement such as this coming from such an authoriative scientific body as the NAS, Deputy Director of National Affairs at the Drug Policy Alliance, Michael Collins said:

“This report is vindication for all the many researchers, patients and healthcare providers who have long understood the benefits of medical marijuana. To have such a thorough review of the evidence conclude that there are benefits to medical marijuana should boost the case for federal reform. It also underlines how out of touch the DEA and other marijuana reform opponents are when they claim otherwise.” [Source]

Key findings in the NAS report of particular interest to advocates of legalization include the following:

  • Cannabis has significant therapeutic benefit in the treatment of chronic pain, for spasms caused by multiple-sclerosis, and in the reduction of discomfort for chemotherapy and radiation treatment patients.
  • Smoking cannabis does not increase the risk for cancers often associated with tobacco use.

The NAS report does not appear to show favoritism in its findings, duly noting and reporting evidence of both the positive and negative aspects of chronic cannabis usage, which includes the increased risk of mental health issues and psychosocial issues due to overuse. However, the report should be considered a win for those advocating for the legalization of cannabis-based therapeutic medicines and remedies, as well as a rejection of the DEA’s classification of cannabis and cannabis extracts as substances devoid of medical benefit.

Read more articles by Alex Pietrowski.

About the Author

Alex Pietrowski is an artist and writer concerned with preserving good health and the basic freedom to enjoy a healthy lifestyle. He is a staff writer for WakingTimes.com and Offgrid Outpost, a provider ofstorable food and emergency kits. Alex is an avid student of Yoga and life.

Like Waking Times on Facebook. Follow Waking Times on Twitter.

This article (National Academy of Sciences Issues Landmark Statement on Medical Cannabis) was originally created and published by Waking Times and is published here under a Creative Commons license with attribution to AlexPietrowski and WakingTimes.com. It may be re-posted freely with proper attribution, author bio, and this copyright statement.

~~ Help Waking Times to raise the vibration by sharing this article with friends and family…

The post National Academy of Sciences Issues Landmark Statement on Medical Cannabis appeared first on Waking Times.



Source: http://www.wakingtimes.com/2017/01/12/national-academy-sciences-issues-landmark-statement-medical-cannabis/

Report abuse

Comments

Your Comments
Question   Razz  Sad   Evil  Exclaim  Smile  Redface  Biggrin  Surprised  Eek   Confused   Cool  LOL   Mad   Twisted  Rolleyes   Wink  Idea  Arrow  Neutral  Cry   Mr. Green

Top Stories
Recent Stories

Register

Newsletter

Email this story
Email this story

If you really want to ban this commenter, please write down the reason:

If you really want to disable all recommended stories, click on OK button. After that, you will be redirect to your options page.